DiaCon Overnight Closed-Loop Glucose Control Study

DiaCon Closed-Loop Study

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01444443

Acronym

DiaCon2

Enrollment

Registered

2011-09-30

Start date

2011-11-30

Completion date

2012-06-30

Last updated

2012-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 1 Diabetes

Keywords

Type 1 diabetes, Glucose control, Closed-loop, Insulin pump, Glucose sensor

Brief summary

The objective of this in-clinic study is to test our closed-loop glucose control system in patients with type 1 diabetes.

Interventions

DEVICEClosed-loop control

Blood glucose controlled by algorithm

OTHEROpen-loop control

Blood glucose controlled by patient

Study design

Allocation

RANDOMIZED

Intervention model

CROSSOVER

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 65 Years

Healthy volunteers

Inclusion criteria

* Age 18-65 years * Type 1 diabetes duration \> 2 years * HbA1c \< 8% * Insulin pump user \> 1 year

Exclusion criteria

* Use of medication affecting glucose metabolism * Pregnancy or nursing

Design outcomes

Primary

Measure	Time frame
Number of hypoglycemic events	22:00-07:00

Secondary

Measure	Time frame
Time spent in euglycemia (3.9-8.0 mmol/l); mean blood glucose level; LBGI	22:00-07:00

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026